Chlorogenic acid protects against liver fibrosis in vivo and in vitro through inhibition of oxidative stress

Clinical Nutrition

Volumn 35, Issue 6, 2016, Pages 1366-1373

  Shi, Haitao ^a   Shi, Ameng ^a   Dong, Lei ^a   Lu, Xiaolan ^a   Wang, Yan ^a   Zhao, Juhui ^a   Dai, Fei ^a   Guo, Xiaoyan ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Chlorogenic acid; Liver fibrosis; NOX; Nrf2; Oxidative stress

Indexed keywords

CATALASE; CHLOROGENIC ACID; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CYTOCHROME P450 2E1; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; HEME OXYGENASE 1; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PLATELET DERIVED GROWTH FACTOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SMOOTH MUSCLE ACTIN; SUPEROXIDE DISMUTASE; SYNAPTOPHYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSCRIPTION FACTOR NRF2; ANTIOXIDANT; CARBON TETRACHLORIDE; GLUTATHIONE PEROXIDASE; HYDROXYPROLINE; MALONALDEHYDE; NFE2L2 PROTEIN, RAT; TISSUE INHIBITOR OF METALLOPROTEINASE-1 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CARBON TETRACHLORIDE-INDUCED LIVER FIBROSIS; CELL VIABILITY; CONTROLLED STUDY; DRUG DETERMINATION; DRUG STRUCTURE; GCLC GENE; GENE; HISTOPATHOLOGY; HO 1 GENE; IN VITRO STUDY; IN VIVO STUDY; MALE; MTT ASSAY; NONHUMAN; NQO1 GENE; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; STELLATE CELL; ANIMAL; CELL SURVIVAL; DISEASE MODEL; DRUG EFFECTS; GENETICS; LIVER; LIVER CIRRHOSIS; METABOLISM; SPRAGUE DAWLEY RAT; TUMOR CELL LINE;

ANIMALS; ANTIOXIDANTS; CARBON TETRACHLORIDE; CELL LINE, TUMOR; CELL SURVIVAL; CHLOROGENIC ACID; CYTOCHROME P-450 CYP2E1; DISEASE MODELS, ANIMAL; GLUTATHIONE PEROXIDASE; HYDROXYPROLINE; LIVER; LIVER CIRRHOSIS; MALE; MALONDIALDEHYDE; NADPH OXIDASES; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 84977085571     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2016.03.002     Document Type: Article

References (46)

1. [1] Mallat, A., Lotersztajn, S., Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis. Am J Physiol Cell Physiol 305 (2013), C789–C799.
2. [2] Schuppan, D., Kim, Y.O., Evolving therapies for liver fibrosis. J Clin Invest 123 (2013), 1887–1901.
3. [3] Lee, Y.A., Wallace, M.C., Friedman, S.L., Pathobiology of liver fibrosis: a translational success story. Gut 64 (2015), 830–841.
4. [4] Iwaisako, K., Brenner, D.A., Kisseleva, T., What's new in liver fibrosis? the origin of myofibroblasts in liver fibrosis. J Gastroenterol Hepatol 27:2 (2012), 65–68.
5. [5] Sanchez-Valle, V., Chavez-Tapia, N.C., Uribe, M., Mendez-Sanchez, N., Role of oxidative stress and molecular changes in liver fibrosis: a review. Curr Med Chem 19 (2012), 4850–4860.
6. [6] Cichoz-Lach, H., Michalak, A., Oxidative stress as a crucial factor in liver diseases. World J Gastroenterol 20 (2014), 8082–8091.
7. [7] Paik, Y.H., Kim, J., Aoyama, T., De Minicis, S., Bataller, R., Brenner, D.A., Role of NADPH oxidases in liver fibrosis. Antioxid Redox Signal 20 (2014), 2854–2872.
8. [8] Paik, Y.H., Iwaisako, K., Seki, E., Inokuchi, S., Schnabl, B., Osterreicher, C.H., et al. The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91(phox) mediate hepatic fibrosis in mice. Hepatology 53 (2011), 1730–1741.
9. [9] De Minicis, S., Seki, E., Paik, Y.H., Osterreicher, C.H., Kodama, Y., Kluwe, J., et al. Role and cellular source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosis. Hepatology 52 (2010), 1420–1430.
10. [10] Adachi, T., Togashi, H., Suzuki, A., Kasai, S., Ito, J., Sugahara, K., et al. NAD(P)H oxidase plays a crucial role in PDGF-induced proliferation of hepatic stellate cells. Hepatology 41 (2005), 1272–1281.
11. [11] Bataller, R., Schwabe, R.F., Choi, Y.H., Yang, L., Paik, Y.H., Lindquist, J., et al. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J Clin Invest 112 (2003), 1383–1394.
12. [12] De Minicis, S., Seki, E., Oesterreicher, C., Schnabl, B., Schwabe, R.F., Brenner, D.A., Reduced nicotinamide adenine dinucleotide phosphate oxidase mediates fibrotic and inflammatory effects of leptin on hepatic stellate cells. Hepatology 48 (2008), 2016–2026.
13. [13] Zhan, S.S., Jiang, J.X., Wu, J., Halsted, C., Friedman, S.L., Zern, M.A., et al. Phagocytosis of apoptotic bodies by hepatic stellate cells induces NADPH oxidase and is associated with liver fibrosis in vivo. Hepatology 43 (2006), 435–443.
14. [14] Guimaraes, E.L., Empsen, C., Geerts, A., van Grunsven, L.A., Advanced glycation end products induce production of reactive oxygen species via the activation of NADPH oxidase in murine hepatic stellate cells. J Hepatol 52 (2010), 389–397.
15. [15] Pinzani, M., Gesualdo, L., Sabbah, G.M., Abboud, H.E., Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J Clin Invest 84 (1989), 1786–1793.
16. [16] Popov, Y., Schuppan, D., Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies. Hepatology 50 (2009), 1294–1306.
17. [17] Zhu, W., Fung, P.C., The roles played by crucial free radicals like lipid free radicals, nitric oxide, and enzymes NOS and NADPH in CCl(4)-induced acute liver injury of mice. Free Radic Biol Med 29 (2000), 870–880.
18. [18] Chen, S., Zou, L., Li, L., Wu, T., The protective effect of glycyrrhetinic acid on carbon tetrachloride-induced chronic liver fibrosis in mice via upregulation of Nrf2. PLoS One, 8, 2013, e53662.
19. [19] Zhang, Q., Pi, J., Woods, C.G., Andersen, M.E., A systems biology perspective on Nrf2-mediated antioxidant response. Toxicol Appl Pharmacol 244 (2010), 84–97.
20. [20] Baird, L., Dinkova-Kostova, A.T., The cytoprotective role of the Keap1-Nrf2 pathway. Arch Toxicol 85 (2011), 241–272.
21. [21] Kaspar, J.W., Niture, S.K., Jaiswal, A.K., Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radic Biol Med 47 (2009), 1304–1309.
22. [22] Ji, L., Jiang, P., Lu, B., Sheng, Y., Wang, X., Wang, Z., Chlorogenic acid, a dietary polyphenol, protects acetaminophen-induced liver injury and its mechanism. J Nutr Biochem 24 (2013), 1911–1919.
23. [23] Yun, N., Kang, J.W., Lee, S.M., Protective effects of chlorogenic acid against ischemia/reperfusion injury in rat liver: molecular evidence of its antioxidant and anti-inflammatory properties. J Nutr Biochem 23 (2012), 1249–1255.
24. [24] Ma, Y., Gao, M., Liu, D., Chlorogenic acid improves high fat diet-induced hepatic steatosis and insulin resistance in mice. Pharm Res 32 (2015), 1200–1209.
25. [25] Ruifeng, G., Yunhe, F., Zhengkai, W., Ershun, Z., Yimeng, L., Minjun, Y., et al. Chlorogenic acid attenuates lipopolysaccharide-induced mice mastitis by suppressing TLR4-mediated NF-kappaB signaling pathway. Eur J Pharmacol 729 (2014), 54–58.
26. [26] Rakshit, S., Mandal, L., Pal, B.C., Bagchi, J., Biswas, N., Chaudhuri, J., et al. Involvement of ROS in chlorogenic acid-induced apoptosis of Bcr-Abl+ CML cells. Biochem Pharmacol 80 (2010), 1662–1675.
27. [27] Cho, A.S., Jeon, S.M., Kim, M.J., Yeo, J., Seo, K.I., Choi, M.S., et al. Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced-obese mice. Food Chem Toxicol 48 (2010), 937–943.
28. [28] Lou, Z., Wang, H., Zhu, S., Ma, C., Wang, Z., Antibacterial activity and mechanism of action of chlorogenic acid. J Food Sci 76 (2011), M398–M403.
29. [29] Ong, K.W., Hsu, A., Tan, B.K., Anti-diabetic and anti-lipidemic effects of chlorogenic acid are mediated by ampk activation. Biochem Pharmacol 85 (2013), 1341–1351.
30. [30] Feng, R., Lu, Y., Bowman, L.L., Qian, Y., Castranova, V., Ding, M., Inhibition of activator protein-1, NF-kappaB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. J Biol Chem 280 (2005), 27888–27895.
31. [31] Suzuki, A., Yamamoto, N., Jokura, H., Yamamoto, M., Fujii, A., Tokimitsu, I., et al. Chlorogenic acid attenuates hypertension and improves endothelial function in spontaneously hypertensive rats. J Hypertens 24 (2006), 1065–1073.
32. [32] Shi, H., Dong, L., Bai, Y., Zhao, J., Zhang, Y., Zhang, L., Chlorogenic acid against carbon tetrachloride-induced liver fibrosis in rats. Eur J Pharmacol 623 (2009), 119–124.
33. [33] Shi, H., Dong, L., Jiang, J., Zhao, J., Zhao, G., Dang, X., et al. Chlorogenic acid reduces liver inflammation and fibrosis through inhibition of toll-like receptor 4 signaling pathway. Toxicology 303 (2013), 107–114.
34. [34] Shi, H., Dong, L., Dang, X., Liu, Y., Jiang, J., Wang, Y., et al. Effect of chlorogenic acid on LPS-induced proinflammatory signaling in hepatic stellate cells. Inflamm Res 62 (2013), 581–587.
35. [35] Vogel, S., Piantedosi, R., Frank, J., Lalazar, A., Rockey, D.C., Friedman, S.L., et al. An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. J Lipid Res 41 (2000), 882–893.
36. [36] Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001), 402–408.
37. [37] Reczek, C.R., Chandel, N.S., ROS-dependent signal transduction. Curr Opin Cell Biol 33 (2015), 8–13.
38. [38] Ray, P.D., Huang, B.W., Tsuji, Y., Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 24 (2012), 981–990.
39. [39] Samarakoon, R., Overstreet, J.M., Higgins, P.J., TGF-beta signaling in tissue fibrosis: redox controls, target genes and therapeutic opportunities. Cell Signal 25 (2013), 264–268.
40. [40] Parola, M., Robino, G., Oxidative stress-related molecules and liver fibrosis. J Hepatol 35 (2001), 297–306.
41. [41] Lushchak, V.I., Free radicals, reactive oxygen species, oxidative stress and its classification. Chem Biol Interact 224C (2014), 164–175.
42. [42] Day, B.J., Antioxidant therapeutics: pandora's box. Free Radic Biol Med 66 (2014), 58–64.
43. [43] Dai, N., Zou, Y., Zhu, L., Wang, H.F., Dai, M.G., Antioxidant properties of proanthocyanidins attenuate carbon tetrachloride (CCl4)-induced steatosis and liver injury in rats via CYP2E1 regulation. J Med Food 17 (2014), 663–669.
44. [44] Singh, S., Vrishni, S., Singh, B.K., Rahman, I., Kakkar, P., Nrf2-ARE stress response mechanism: a control point in oxidative stress-mediated dysfunctions and chronic inflammatory diseases. Free Radic Res 44 (2010), 1267–1288.
45. [45] Shin, S.M., Yang, J.H., Ki, S.H., Role of the Nrf2-ARE pathway in liver diseases. Oxid Med Cell Longev, 2013, 2013, 763257.
46. [46] Xu, W., Hellerbrand, C., Kohler, U.A., Bugnon, P., Kan, Y.W., Werner, S., et al. The Nrf2 transcription factor protects from toxin-induced liver injury and fibrosis. Lab Invest 88 (2008), 1068–1078.